Fact CheckerSign in

NCT06223022Enrolling by invitation

Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment

How Are You Getting on? Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment Increases Their Sense of Security and Well-being

Source: ClinicalTrials.gov · Last updated 2 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this randomized study is to test and evaluate nurse-led telephone follow-up intervention in patients primarily curatively treated for breast cancer, colorectal cancer, and prostate cancer. The main question aims to answer: Does this nurse-led telephone follow-up improve patients' quality of life? Participants in both groups will be asked to fill in questionnaires regularly. The intervention group will get a telephone follow-up at predetermined intervals, while the control group will get the care as usual.The investigators will compare intervention and control groups to see if predetermined regular nurse-led telephone follow-up improves quality of life.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
512 (estimated)
First submitted
4 Dec 2023
Start date
20 Jan 2024
Primary completion date
30 Apr 2026
Lead sponsor
Umeå University
NCT number
NCT06223022

What you commit to

  • Study type: Interventional
  • Planned participants: 512
  • From 20 Jan 2024 to the primary completion date, 30 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • no cognitive impairment

Other

  • no adjuvant treatment
  • no known alcohol or other misuse

Who the study is looking for

  • Being primarily curatively treated for breast, colorectal-, or prostate cancer

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Norrlands universitetssjukhus
Coordinator of this site? Confirm its status
UmeåSwedenUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.